Molecular assembly for high-performance bivalent nucleic acid inhibitor.
about
Fluorescence-Based Strategies to Investigate the Structure and Dynamics of Aptamer-Ligand ComplexesMethods for Improving Aptamer Binding AffinityMultivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic ApplicationsAptamers in analytics.Bioinspired multivalent DNA network for capture and release of cells.Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy.Single-pair fluorescence resonance energy transfer (spFRET) for the high sensitivity analysis of low-abundance proteins using aptamers as molecular recognition elementsRecent developments in protein and cell-targeted aptamer selection and applicationsAptamers from cell-based selection for bioanalytical applicationsNew strategy for the synthesis of chemically modified RNA constructs exemplified by hairpin and hammerhead ribozymesAn autonomous and controllable light-driven DNA walking device.A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemiaAptamer-modified nanodrug delivery systemsPost-SELEX optimization of aptamers.Aptamer-aptamer linkage based aptasensor for highly enhanced detection of small molecules.Generating DNA synbodies from previously discovered peptides.Protein quantification using controlled DNA melting transitions in bivalent probe assemblies.Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant.Light-up and FRET aptamer reporters; evaluating their applications for imaging transcription in eukaryotic cells.Using photons to manipulate enzyme inhibition by an azobenzene-modified nucleic acid probe.Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices.Oligonucleotide-Based Systems for Input-Controlled and Non-Covalently Regulated Protein-BindingRobust and specific ratiometric biosensing using a copper-free clicked quantum dot-DNA aptamer sensor.A review of therapeutic aptamer conjugates with emphasis on new approaches.The chemical biology of aptamers.Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.Nucleic acid conjugated nanomaterials for enhanced molecular recognition.Aptamers generated by Cell SELEX for biomarker discovery.Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging.Aptamer-assembled nanomaterials for biosensing and biomedical applications.Engineering target-responsive hydrogels based on aptamer-target interactions.Aptamers act as activators for the thrombin mediated-hydrolysis of peptide substrates.Directly investigating the interaction between aptamers and thrombin by atomic force microscopy.Interaction of water with the G-quadruplex loop contributes to the binding energy of G-quadruplex to protein.Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cellsHighly efficient control of thrombin activity by multivalent nanoparticles.Bi-specific aptamers mediating tumor cell lysis.Composite RNA aptamers as functional mimics of proteins.Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
P2860
Q26740493-F8D3738B-7BFE-4212-9F9A-ED514E6ABBEBQ26752642-3841D605-EDB4-440F-A495-BC1F91B811D5Q28073119-C958C0A5-6329-4B94-88FF-475C77A655AAQ28075607-8193D082-AA96-4DC8-8BF5-7A0703E8D372Q30528846-22B1CB74-C75E-4BA4-8B04-EEDFB12AE6C4Q33598723-F3B502AF-846A-4EFA-B90D-EDE150DE87E0Q33791768-5C65F6F1-B299-445F-A359-E56E68A9EDDBQ33824619-4D1F8911-8EE9-4507-BD16-8D9E4D1572EEQ33908491-635D7156-2BE1-4D7E-AF52-160F0B191F1CQ33920514-53E9D292-FD2A-4E8A-AC18-E834EDE0593BQ34100535-BFEB448E-96C7-4772-9C23-E522EE0D6701Q34251281-931F39B2-5859-42A2-95C2-D5EFA8558E63Q34723932-9F9DDD26-A79B-405D-BB26-071D2118F9CFQ35633429-B2D42860-AA01-4E60-9D75-58128F5020C4Q36016288-6A254D74-F611-4528-BA8C-5689F8C32B18Q36028525-50D145CF-10B1-40BF-8792-C8B05BE12C05Q36079650-81AE310C-9F15-4004-BB43-17F1A7A4FAA2Q36146845-835BE7DC-804C-4314-82FC-5134F6FFFC7EQ36580126-3B743FBE-DA7C-41BC-862A-DE9AAAA66856Q36730738-9D5C3541-65EA-4F0B-AE9B-C2362E79E55BQ37167839-720DD2FC-742C-4833-8D8D-8652B5042C54Q37202667-9A494443-76A8-4A7A-8826-879D6946EBB4Q37262541-8AC82FC1-DA0C-4210-BD93-951A5B2E2424Q37270723-ECD0AF5B-E6EC-4CB3-85D6-F910F40372A6Q37277378-DA3D4215-297A-4EA0-B78F-9C6969932D2FQ37423243-BA6F7B8A-9527-4F85-B47F-5CCC30B1D996Q37426582-FF6D2FE9-09A5-482A-AB21-6AA32F5D560DQ37573694-025E051B-7E2D-45D1-8FF3-97F420A006E2Q37755162-945A2031-5204-49D2-B597-3A325C28D276Q37821356-7C04CE50-88F9-4439-AFA8-36FE546CD2E6Q37897203-51C39580-6065-4CF8-9E70-68A20CD96D81Q38291421-D5F33D4B-25BE-4A36-AA6A-7062D250E119Q38310364-229690A7-0F11-467C-9D27-529B0BBB2076Q38310890-04489F2C-B6F0-464B-A60E-AFDEF65927E3Q38323015-18AC316A-80FB-473B-B91D-B9FEB9C3F963Q38326261-1BD7C0AA-0D36-466C-AA3F-B53C862039B8Q38332550-2E051FD8-B208-4D34-8E1E-D0CBDC50B47AQ38335529-0C47AC78-89FD-4DF7-BF2A-C1953EFAF5F6Q38437211-847A3160-7772-4EB5-9F74-D3559974E8A5Q38771180-B34DF46B-4BD4-424C-AF95-DA323C62DA18
P2860
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
@ast
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
@en
type
label
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
@ast
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
@en
prefLabel
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
@ast
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
@en
P2093
P2860
P356
P1476
Molecular assembly for high-performance bivalent nucleic acid inhibitor.
@en
P2093
Weihong Tan
Youngmi Kim
P2860
P304
P356
10.1073/PNAS.0711803105
P407
P577
2008-04-08T00:00:00Z